- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02218710
Bone Structure in Patients With Adult Onset Growth Hormone Deficiency Assessed Using High Resolution Peripheral Quantitative Computed Tomography
August 14, 2014 updated by: Marianne Andersen, Odense University Hospital
Bone Geometry, Volumetric Density, Microarchitecture and Estimated Bone Strength Assessed by High Resolution Peripheral Quantitative Computed Tomography in Patients With Adult Onset Growth Hormone Deficiency
The aim of the study is to assess bone geometry, bone compartment specific volumetric densities and micro-architecture as well as to evaluate non-invasive estimates of bone strength in patients with adult onset growth hormone deficiency.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
45
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kristian Buch, Stud.med
- Phone Number: +45 29434376
- Email: krbuc08@student.sdu.dk
Study Locations
-
-
Region syddanmark
-
Odense, Region syddanmark, Denmark, 5000
- Endocrinological department M, Odense University Hospital
-
Principal Investigator:
- Kim Brixen, MD, PhD
-
Sub-Investigator:
- Marianne Andersen, MD, PhD
-
Sub-Investigator:
- Dorthe Glintborg, MD, PhD
-
Sub-Investigator:
- Frantz Rom Poulsen, MD, PhD
-
Sub-Investigator:
- Claus Andersen, MD
-
Sub-Investigator:
- Stinus Hansen, MD, PhD
-
Sub-Investigator:
- Vikram Vinod Shanbhogue, MD
-
Sub-Investigator:
- Kristian Buch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients are all seen at the Odense University Hospital at the department of Endocrinology.
All patients at the hypophysis clinic were checked and those receiving growth hormone replacement therapy were invited to participate.
Description
Inclusion Criteria:
- Men and women diagnosed with Adult onset Growth Hormone Deficiency
- Age between 18-80
- Informed consent
Exclusion Criteria:
- Competing bone disease (e.g.. Mb. Paget, myelomatosis, osteogenesis imperfecta, osteoporosis, primary hyperparathyroidism)
- Ongoing medical treatment affecting bone metabolism (eg. osteoporosis medications)
- Ongoing pregnancy or breast feeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
healthy controls
|
Growth hormone deficiency
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
volumetric bone mineral density in grams per cc
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Anticipated)
June 1, 2015
Study Registration Dates
First Submitted
August 7, 2014
First Submitted That Met QC Criteria
August 14, 2014
First Posted (Estimate)
August 18, 2014
Study Record Updates
Last Update Posted (Estimate)
August 18, 2014
Last Update Submitted That Met QC Criteria
August 14, 2014
Last Verified
August 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- S-20120156
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adult Onset Growth Hormone Deficiency
-
Garcia, Jose M., MD, PhDCompletedAdult-Onset Growth Hormone DeficiencyUnited States
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyFrance
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyDenmark
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyGermany
-
Altus PharmaceuticalsCompleted
-
OPKO Health, Inc.CompletedAdult Growth Hormone DeficiencyCzechia, Hungary, Israel, Serbia, Slovakia, Slovenia
-
Novo Nordisk A/SCompletedHealthy | Growth Hormone Disorder | Adult Growth Hormone DeficiencyUnited States
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyGermany
-
AEterna ZentarisCompletedDiagnosis of Adult Growth Hormone Deficiency (AGDH)United States
-
Merck KGaA, Darmstadt, GermanyCompletedAdult Growth Hormone Deficiency